[144] Golden Matrix Group, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Golden Matrix Group, Inc. (GMGI) reports a proposed sale of 50,000 common shares on or about 08/18/2025 through Oppenheimer & Co., with an aggregate market value listed as $66,995. The filer indicates the shares were acquired as compensation on 09/16/2021. The filing also discloses multiple recent secondary-market sales by the same person during the past three months: seven separate sales of 50,000 shares each between 06/30/2025 and 08/11/2025, generating gross proceeds ranging from $67,535 to $87,150 per trade. Outstanding shares are listed as 139,483,065. The filer affirms no undisclosed material adverse information.

Positive

• Disclosure is complete for a Rule 144 notice: broker, acquisition date, planned sale date, and amount are provided.

Negative

• Insider selling pattern: multiple recent sales of 50,000 shares each over the last two months may be viewed negatively by some investors.

Insights

Financial Analyst

TL;DR: Routine insider disposition of a modest block; multiple recent sales suggest ongoing liquidity needs rather than corporate event.

The filing shows a proposed sale of 50,000 common shares (~0.036% of outstanding shares) and documents a pattern of seven prior 50,000-share dispositions over the past six weeks. The shares were granted as compensation in 2021, so these are not recent acquisitions. The trade sizes are small relative to total float, making this unlikely to materially affect market capitalization. Investors should view this as an insider selling pattern rather than an operational signal from company disclosures.

Compliance/Risk Analyst

TL;DR: Form 144 appears complete for a Rule 144 notice; no red flags in the filing mechanics.

The notice identifies the broker, planned sale date, acquisition date, and that the securities were received as compensation — consistent with Rule 144 disclosure requirements. The filer certifies lack of undisclosed material adverse information. There is no indication of a 10b5-1 plan date on the face of the form. From a compliance perspective the document contains required fields; regulators would likely accept it as a routine notification of proposed resale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Oppenheimer & Co, Inc 85 Broad St New York NY 10004	50000	66995.00	139483065	08/18/2025	nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2021	Compensation	Issuer			50000	09/16/2021	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Anthony Brian Goodman 3651 Lindell Rd Las Vegas NV 89103	Common	08/11/2025	50000	67535.00
Anthony Brian Goodman 3651 Lindell Rd Las Vegas NV 89103	Common	08/04/2025	50000	74710.00
Anthony Brian Goodman 3651 Lindell Rd Las Vegas NV 89103	Common	07/28/2025	50000	80965.00
Anthony Brian Goodman 3651 Lindell Rd Las Vegas NV 89103	Common	07/21/2025	50000	81435.00
Anthony Brian Goodman 3651 Lindell Rd Las Vegas NV 89103	Common	07/14/2025	50000	87150.00
Anthony Brian Goodman 3651 Lindell Rd Las Vegas NV 89103	Common	07/07/2025	50000	85400.00
Anthony Brian Goodman 3651 Lindell Rd Las Vegas NV 89103	Common	06/30/2025	50000	87250.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the GMGI Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 50,000 common shares on or about 08/18/2025 through Oppenheimer & Co., with an aggregate market value of $66,995.

How many shares has the filer recently sold for GMGI?

The filer completed seven sales of 50,000 shares each between 06/30/2025 and 08/11/2025, totaling 350,000 shares sold in the past three months.

When were the shares being sold originally acquired?

The shares to be sold were acquired as compensation on 09/16/2021 according to the filing.

How large is the intended sale relative to outstanding shares of GMGI?

The proposed 50,000-share sale represents approximately 0.036% of the reported 139,483,065 outstanding shares.

Does the filing indicate any undisclosed material information?

The filer signs a representation stating they do not know of any material adverse information about the issuer that has not been publicly disclosed.